Enliven Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $529k | 26k | 20.47 |
| 2025-06-30 | $334k | 17k | 20.06 |
| 2025-03-31 | $349k | 18k | 19.68 |
| 2024-12-31 | $375k | 17k | 22.50 |
| 2024-09-30 | $284k | 11k | 25.54 |
| 2024-06-30 | $269k | 12k | 23.37 |
| 2024-03-31 | $145k | 8.2k | 17.59 |
| 2023-12-31 | $99k | 7.2k | 13.84 |
| 2023-09-30 | $78k | 5.7k | 13.66 |
| 2023-06-30 | $181k | 8.9k | 20.41 |